Hologic, Inc. (HOLX) is set to unveil groundbreaking technologies at the 110th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, to be held from Dec. 1-5. With a focus on enhancing breast health care, the company will showcase AI-powered breast imaging advancements designed to assess breast density, enhance workflows and improve cancer detection.Additionally, in the same event, Hologic will present the results of a recently published study demonstrating t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: September 28, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 1-36214 _________________________________________________ ...

Hologic, Inc.’s (HOLX) robust strength in the Molecular Diagnostics business is poised to drive growth in the upcoming quarters. Solid demand for breast imaging solutions aids the Breast Health division’s growth, with the company’s new buyout further diversifying the business. On top of that, broad-based performance in the international markets is highly promising for the stock. Meanwhile, the uncertain macroeconomic volatilities as well as adverse currency fluctuations can dent Hologic’s operations.In the ...

On Monday, Hologic (HOLX) released its fiscal 2024 fourth-quarter financial report after the closing bell, with revenues slightly surpassing the consensus mark. The bottom line fell short of estimates by just 1% after three consecutive quarters of positive surprises. However, both metrics improved on a year-over-year basis. Closing the year with a solid operating margin, Hologic emerged as a top-tier performer within its peer group, with room for improvement in fiscal 2025.Shares of the Marlborough, MA-base ...

Hologic, Inc. (HOLX) reported adjusted earnings per share (EPS) of $1.01 in the fourth quarter of fiscal 2024, up 13.5% year over year. However, the bottom line missed the Zacks Consensus Estimate by 0.9%.The adjustments include charges and benefits related to the amortization of acquired intangible assets, restructuring and integration/consolidation costs and many others.The company’s GAAP EPS was 76 cents in the quarter compared with 37 cents in the year-ago period.Fiscal 2024 adjusted EPS was $4.08, up 3 ...

Hologic, Inc. (NASDAQ:HOLX) Q4 2024 Earnings Conference Call November 4, 2024 4:30 PM ET Company Participants Ryan Simon - Vice President, Investor Relations Stephen MacMillan - Chairman, President & Chief Executive Officer Essex Mitchell - Chief Operating Officer Karleen Oberton - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Anthony Petrone - Mizuho Group Vijay Kumar - Evercore ISI Casey Woodring - JPMorgan Mike Matson - Needham & Company Nava ...

For the quarter ended September 2024, Hologic (HOLX) reported revenue of $987.9 million, up 4.5% over the same period last year. EPS came in at $1.01, compared to $0.89 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $979.28 million, representing a surprise of +0.88%. The company delivered an EPS surprise of -0.98%, with the consensus EPS estimate being $1.02.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...

Hologic (HOLX) came out with quarterly earnings of $1.01 per share, missing the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.89 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -0.98%. A quarter ago, it was expected that this medical device maker would post earnings of $1.02 per share when it actually produced earnings of $1.06, delivering a surprise of 3.92%.Over the last four quarters, the comp ...

Exhibit 99.1 Hologic Announces Financial Results for Fourth Quarter of Fiscal 2024 – Revenue of $987.9 Million, GAAP Diluted EPS of $0.76 and Non-GAAP Diluted EPS of $1.01 – – Total Company Revenue Growth of 4.5%, or 4.2% in Constant Currency and 5.0% Organically ex. COVID-19 in Constant Currency – – Company Expects Strong Execution of its Broad-Based Growth Strategy in Fiscal 2025 – MARLBOROUGH, Mass. (November 4, 2024) – Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the ...

Analysts on Wall Street project that Hologic (HOLX) will announce quarterly earnings of $1.02 per share in its forthcoming report, representing an increase of 14.6% year over year. Revenues are projected to reach $979.28 million, increasing 3.6% from the same quarter last year. Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 2.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this peri ...